Pharmacological evaluation of a new Ca++ antagonist, 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride (TMB-8): studies in skeletal muscles.
D000109:Acetylcholine / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001001:Anura; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D002645:Chickens; D003864:Depression, Chemical; D003964:Diaphragm / Q000187:drug effects; D004048:Diethylamines / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D005707:Gallic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D009210:Myofibrils / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology; D010791:Phrenic Nerve / Q000187:drug effects; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D012584:Sciatic Nerve / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*
D004048:Diethylamines; D002110:Caffeine; D005707:Gallic Acid; D011189:Potassium Chloride; D009538:Nicotine; D000109:Acetylcholine; D002118:Calcium